Ушбу иш иқтибос қилган ишлар

128 та иш

Иш: Toad venom bufadienolides and bufotoxins: An updated review

1. Chemical composition and biological activity of total bufadienolides from the Central-Asian Bufo viridis toad venom

   Azamjon B. Soliev, Sh. Ya. Mirzaakhmedov, М. С. Ташмухамедов +7

   МақолаIon Transport and Channel RegulationPharmaceutical Chemistry Journal20076 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.074979

2. Advances on Tumor-Targeting Delivery of Cytotoxic Proteins

   Akmal M. Asrorov, Zeyun Gu, Kyoung Ah Min +2

   Шарҳ мақолаToxin Mechanisms and ImmunotoxinsACS Pharmacology & Translational Science20196 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.075040

3. Biomimetic camouflage delivery strategies for cancer therapy

   Akmal M. Asrorov, Zeyun Gu, Feng Li +2

   Шарҳ мақолаNanoplatforms for cancer theranosticsNanoscale20216 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.075056

4. Chemical profiling and cytotoxicity assay of bufadienolides in toad venom and toad skin

   Qiong Meng, Lee‐Fong Yau, Jing‐Guang Lu +4

   Мақола20163 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.074984

5. Platelet membrane biomimetic bufalin-loaded hollow MnO2 nanoparticles for MRI-guided chemo-chemodynamic combined therapy of cancer

   Haijun Wang, David H. Bremner, Kunhua Wu +6

   Мақола20193 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.075036

6. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway

   Dongmei Zhang, Jun-Shan Liu, Lijuan Deng +8

   Мақола20132 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.074946

7. Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells

   Zhenlong Yu, Wei Guo, Xiaochi Ma +15

   Мақола20142 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.074950

8. Bufadienolides of plant and animal origin

   Pieter S. Steyn, Fanie R. van Heerden

   Шарҳ мақола19982 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.074951

9. Simultaneous determination of cytotoxic bufadienolides in the Chinese medicine ChanSu by high-performance liquid chromatography coupled with photodiode array and mass spectrometry detections

   Min Ye, Hui Guo, Hongzhu Guo +2

   Мақола20062 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.074960

10. Comparison of toad venoms from different Bufo species by HPLC and LC-DAD-MS/MS

    Hui‐Min Gao, Martin Zehl, Alexander Leitner +3

    Мақола20102 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.074966

11. MiR-181a contributes to bufalin-induced apoptosis in PC-3 prostate cancer cells

    Xiaofeng Zhai, Fanfu Fang, Qun Liu +3

    Мақола20132 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.074976

12. Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway

    Ning Tang, Lei Shi, Zhenlong Yu +11

    Мақола20152 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.074980

13. Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells

    Qing‐Xi Yue, Hong Zhen, Ming Huang +7

    Мақола20162 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.074996

14. Bufadienolides from amphibians: A promising source of anticancer prototypes for radical innovation, apoptosis triggering and Na+/K+-ATPase inhibition

    Lívia Queiroz de Sousa, Kátia da Conceição Machado, Samara Ferreira de Carvalho Oliveira +5

    Шарҳ мақола20172 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.075001

15. Bufalin-loaded bovine serum albumin nanoparticles demonstrated improved anti-tumor activity against hepatocellular carcinoma: preparation, characterization, pharmacokinetics and tissue distribution

    Huiqing Zhang, Huang Nian, Geliang Yang +2

    Мақола20172 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.075007

16. Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery

    Haijun Wang, Junzi Wu, Gareth R. Williams +4

    Мақола20192 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.075032

17. Cytotoxicity potential of chemical constituents isolated and derivatised from Rhinella marina venom

    Evaldo dos Santos Monção Filho, Mariana Helena Chaves, Paulo Michel Pinheiro Ferreira +5

    Мақола20212 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.075054

18. Toad venom: A comprehensive review of chemical constituents, anticancer activities, and mechanisms

    Fang‐Jie Li, Jinghong Hu, Xin Ren +3

    Шарҳ мақола20212 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.075055

19. Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone

    Muzaffar Kayumov, Jia Li, Azizbek Pardaev +9

    МақолаPARP inhibition in cancer therapyEuropean Journal of Medicinal Chemistry20222 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.075060

20. Bufadienolides originated from toad source and their anti-inflammatory activity

    Denglang Zou, Qiqi Wang, Tao Chen +8

    Шарҳ мақола20222 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.075061

21. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.074934

22. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.074935

23. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.074936

24. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.074937

25. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.074938